News
Search EMA's news announcements
EMA annual report 2024 and network strategy to 2028 adopted
PRAC carried out its broad range of responsibilities for managing the risks associated with medicine use
Authorities warn about unregulated products in the EU, including dendritic cell cancer therapies
Rui Santos Ivo elected for three-year term
Patients can locate trials for potential enrolment in their area
Four new medicines recommended for approval; another 16 medicines recommended for extension of their therapeutic indications
Positive opinion for extension of indication brings disease-modifying treatment to all cystic fibrosis patients with modulator responsive mutations
Vyjuvek expected to bring substantial therapeutic benefits and improve quality of life for patients with ultra-rare genetic skin disorder
Eco-Management and Audit Scheme (EMAS) certificate is a mark of environmental excellence in the EU
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting